The average number of industry-funded trials started per month was 135.8 before the IRA was passed and 83.6 after — a 38.4% decrease.

A financial toxicity tumor board has effectively reduced financial toxicity for cancer patients, researchers say.

A prognostic index can be used to identify patients with estrogen receptor (ER)-positive, HER2-negative early breast cancer who can safely forgo adjuvant chemotherapy as well as patients who require ...

President Donald Trump’s proposed budget for fiscal year 2026 would reduce the NIH budget by nearly $18 billion.

The FDA has granted fast track designation to INX-315 for the treatment of CCNE1-amplified, platinum-resistant/refractory ovarian cancer.

In an interview, FDA Commissioner Marty Makary opened up about his first weeks on the job and his vision for the future.

Adding penpulimab to chemotherapy can improve progression-free survival for patients with recurrent or metastatic nasopharyngeal carcinoma, data suggest.

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

Source: Getty Images The combinations tested in the ORCHARD, SAVANNAH, and ETOP AMAZE-Lung trials could be chemotherapy-free alternatives for patients with EGFR-mutant, advanced NSCLC who have ...

ctDNA was detected a median of 198 days before recurrence was found via imaging. New research suggests that a circulating tumor DNA (ctDNA) assay can detect colorectal cancer recurrence months ...

Using both liquid and tissue biopsies to guide targeted treatment may improve outcomes in patients with solid tumor malignancies.

The US nursing workforce remains under immense pressure due to stress, burnout, and persistent short staffing, according to a report.